首页>
外国专利>
Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale
Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale
展开▼
机译:宫内胎儿生长受限-临床研究的治疗方式和生化原理
展开▼
页面导航
摘要
著录项
相似文献
摘要
Intrauterine Fetal Growth Restriction (IUGR) is a very important clinical problem for which no satisfactory treatment is available so far. The current invention of intravenous (IV) hypertonic glucose supplementation to the mother to improve the glucose transfer to the fetus at the intervillous space by improved facilitated diffusion can be a safe and easy way of treating this problem, as the improved fetal blood glucose can lead to fetal lipogenesis that can conserve the fetal O2 (oxygen) utilization and also relieve the associated metabolic derangements of fetal hypoxia, hypercapnia, and acidosis, apart from replenishing the oxidized coenzymes needed for the carbohydrate metabolism. The use of trans-amniotic fetal feeding studied by animal experiments can be difficult in humans, because of the danger of infection, which can be overcome by the use of implantable ports with a sterile patch technique.
展开▼